News

Read full article by Gail Dutton on www.biospace.com

This facility utilizes cutting-edge technology and a flexible design to support the production of Moderna's mRNA-based medicines. It features a fully digital infrastructure and can produce multiple products simultaneously, which allows for efficient and rapid response to emerging health threats. We are thrilled to have played a role in the development of this innovative facility and look forward to continuing to support Moderna's mission to improve human health using mRNA technology.

NECI contributed to the project by providing automation and control solutions that ensured the smooth operation and coordination of the various systems integrated into the facility. NECI’s expertise in process control and instrumentation played a vital role in ensuring the facility's success.